Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Bohumila Fahmy
Institution:
Janssen Research & Development (United States)
Observed institutions:
Johnson & Johnson (United States),
Janssen Research & Development (United States)
OpenAlex ID:
A5112445136
Imidazopyrimidines, potent inhibitors of p38 MAP kinase
2003
·
Kenneth C Rupert
, James R Henry
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
276
RWJ 67657, a Potent, Orally Active Inhibitor of p38 Mitogen-Activated Protein Kinase
1999
·
Scott A. Wadsworth
, Druie E. Cavender
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
167
6-Amino-2-(4-fluorophenyl)-4-methoxy-3- (4-pyridyl)-1H-pyrrolo[2,3-b]pyridine (RWJ 68354): A Potent and Selective p38 Kinase Inhibitor
1998
·
James R. Henry
, Kenneth C. Rupert
, et al.
·
Journal of Medicinal Chemistry
·
79
Inhibitors of unactivated p38 MAP kinase
2006
·
James Bullington
, Dennis Argentieri
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
12
Identification of anti-CD3 antibodies that do not modulate antigen but induce mitogenesis and block the mixed lymphocyte reaction
1992
·
Patricia E. Rao
, Walter Newman
, et al.
·
Human Immunology
·
3
Imidazopyrimidines, Potent Inhibitors of p38 MAP Kinase.
2003
·
Kenneth C. Rupert
, James R. Henry
, et al.
·
ChemInform
·
2
Show more works
View as search
Works count:
6
Citation count:
539
H-index:
4
I10-index:
4
Year
Topic
Type